Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index; 8 of the 43 sources its claims cite were checked for support.

Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome

Open access
Shang, Yujie, Zhou, Huifang, Hu, Minghui, Feng, Hua · 2020 · The Journal of Clinical Endocrinology & Metabolism

Abstract

OBJECTIVE: The effect of diet on insulin resistance (IR) in polycystic ovary syndrome (PCOS) is controversial. Thus, we conducted this systematic review and meta-analysis to evaluate whether diet could reduce IR in women with PCOS while providing optimal and precise nutrition advice for clinical practice. DESIGN: The search was conducted in 8 databases through June 30, 2019. The systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A random-effects model was adopted to calculate the overall effects. RESULTS: A total of 19 trials (1193 participants) were included. The analysis showed that diet was significantly related to improvements in IR and body composition (eg, homeostasis model assessment of insulin resistance, fasting insulin, fasting plasma glucose, body mass index [BMI], weight, and waist circumference) in PCOS patients. The Dietary Approaches to Stop Hypertension diet and calorie-restricted diets might be the optimal choices for reducing IR and improving body composition, respectively, in the PCOS population. Additionally, the effects were associated with the course of treatment. The longer the duration, the greater the improvement was. Compared with metformin, diet was also advantageous for weight loss (including BMI and weight) and had the same effects on insulin regulation. CONCLUSION: Overall, our findings suggest that diet is an effective, acceptable and safe intervention for relieving IR, and professional dietary advice should be offered to all PCOS patients.

Overview

CoChat Summary

TL;DR

In this systematic review and meta-analysis of 19 RCTs (1193 women with PCOS), dietary interventions significantly improved insulin resistance and body composition compared with minimal intervention. Diet was comparable to metformin for insulin outcomes and superior for weight/BMI loss, with DASH and calorie-restricted diets appearing optimal for IR and weight management, respectively.

Key findings

  • Diet versus minimal intervention significantly reduced HOMA-IR (MD = –0.78, 95% CI –0.92 to –0.65; P < .00001; I² = 24%), fasting insulin (MD = –4.24 mIU/L, 95% CI –5.37 to –3.10; P < .00001; I² = 80%), fasting plasma glucose (MD = –0.11 mmol/L, 95% CI –0.17 to –0.04; P = .002; I² = 0%), BMI (MD = –1.01 kg/m², 95% CI –1.38 to –0.64; P < .00001; I² = 54%), weight (MD = –1.74 kg, 95% CI –2.42 to –1.05; P < .00001; I² = 59%), and waist circumference (MD = –3.25 cm, 95% CI –5.29 to 1.22 cm; P = .002; I² = 41%); waist–hip ratio did not change significantly (MD = –0.01, 95% CI –0.02 to 0.00; P = .20; I² = 0%).
  • Subgroup analyses suggested the DASH diet was more beneficial for HOMA-IR than a low-carbohydrate diet, and calorie-restricted diets were more beneficial for BMI and weight; longer treatment duration was associated with greater improvement, except for fasting plasma glucose.
  • Diet versus metformin showed no differences in HOMA-IR (MD = –0.09, 95% CI –0.46 to 0.28; P = .63; I² = 38%), fasting insulin (MD = –0.15 mIU/L, 95% CI –1.34 to 1.04; P = .81; I² = 45%), or fasting plasma glucose (MD = 0.01 mmol/L, 95% CI –0.13 to 0.15; P = .85; I² = 53%).
  • Compared with metformin, diet produced greater reductions in BMI (MD = –2.49 kg/m², 95% CI –2.73 to –2.25; P < .00001; I² = 0%), weight (MD = –5.46 kg, 95% CI –5.79 to –5.13; P < .00001; I² = 0%), and waist circumference (MD = –3.63 cm, 95% CI –7.18 to –0.08; P = .05; I² = 0%); the paper reports no additional benefit for waist–hip ratio (MD = –0.06, 95% CI –0.10 to –0.02; P = .003; I² = 86%).

Methods

  • Systematic review and meta-analysis following PRISMA guidelines, registered in PROSPERO (CRD42019140454); 8 databases were searched through June 30, 2019.
  • Included 19 RCTs with 1193 women diagnosed with PCOS: 15 trials compared diet with minimal intervention (853 participants) and 4 compared diet with metformin (340 participants); dietary patterns included low-carbohydrate, DASH, calorie-restricted, low-fat, and Mediterranean diets, with intervention durations from 4 weeks to 1 year.
  • Random-effects models were used to calculate pooled mean differences or standardized mean differences with 95% CIs; heterogeneity was assessed with Cochran’s Q and I², with subgroup analyses by dietary pattern and treatment duration (≤12 weeks or >12 weeks), sensitivity analysis excluding high-risk-of-bias trials, and Egger’s test/funnel plots when more than 10 trials were available.

Limitations

  • Stated by the authors: evidence involved few countries and ethnic groups; limited numbers of trials and small sample sizes for some outcomes; heterogeneity was present in some results due to differing dietary patterns, metformin dosages, and population characteristics; no included trials targeted a specific PCOS phenotype; most trials lasted ≤12 weeks; and the impact of diet independent of weight loss remains unclear.
  • Evident from the text: only 1 trial explained allocation concealment, 4 trials were judged high risk due to >20% attrition, and publication-bias tests were low-powered because fewer than 10 studies were available for most outcomes.
  • Stated by the authors: meta-regression was limited by the paucity of available studies, and the results for waist circumference and waist–hip ratio in the diet-versus-metformin comparison should be interpreted with caution.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa425

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

8 Valid · 0 Not valid · 12 Not checked · 27 Own results and interpretations

14 more claims

Create a free account to see all 47 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 12
  • It may state two separate claims as one. 18

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 71 references

Research works printed but not linked: 7

  1. 2014, Review Manager (RevMan) [Computer program]. Version 5.3
  2. Cheng, 2016, Effect of diet intervention on quality of life and fasting insulin levels in patients with polycystic ovary syndrome, Tianjin J Nurs., 24, 249
  3. Xu, 2017, Effects of Mediterranean diet on reproductive function in patients with obese polycystic ovary syndrome, Matern Child Heal Care China., 32, 122
  4. Li, 2017, The effect of dietary guidance on polycystic ovary syndrome, J Med Theory Pract., 30, 3745
  5. Li, 2017, Clinical observation of personalized diet intervention and metformin in the treatment of polycystic ovary syndrome, Matern Child Heal Care China., 32, 2535
  6. Ge, 2017, Effect of individualized diet intervention on insulin resistance and pregnancy in infertile patients with PCOS, ACTA Acad Med QINGDAO Univ., 53, 523
  7. Josiemer, 2017, The Mediterranean diet score is more strongly associated with favorable cardiometabolic risk factors over 2 years than other diet quality indexes in Puerto Rican adults, J Nutr., 147

Cited by

See all 171

Metadata

Authors
Shang, Y., Zhou, H., Hu, M., & Feng, H.
Affiliations
Nanjing University of Chinese Medicine (CN)
Corresponding author
Zhou, Huifang
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-07-04
Volume
105
Issue
10
Pages
3346-3360
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3038172358
Cited by
171
References
71
Citations by year
2026: 21 · 2025: 29 · 2024: 31 · 2023: 36 · 2022: 31 · 2021: 19 · 2020: 4
FWCI
3.32
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81774354, 81973898)
  • Jiangsu Administration of Traditional Chinese Medicine Bureau (ZD201702)
  • Jiangsu Leading Talents Project of Traditional Chinese Medicine (SLJ0202)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
polycystic ovary syndrome, insulin resistance, dietary intervention, DASH diet, calorie-restricted diet, body composition, weight loss, metformin, fasting insulin, waist circumference, body mass index
MeSH terms
Dietary Approaches To Stop Hypertension, Blood Glucose, Counseling, Dietary Services, Fasting, Female, Humans, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, Time Factors, Weight Loss, Body Mass Index, Treatment Outcome, Caloric Restriction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.1210/clinem/dgaa425
The paper
Shang, Y., Zhou, H., Hu, M., & Feng, H. (2020). Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaa425

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.